Structure | Chemical Name | CAS | MF |
|
LAGER
|
|
|
|
LAGERSTROEMIASPECIOSA
|
|
|
|
LAGERBEER
|
|
|
|
LAGER SHANDY - ALCOHOL(CRM STANDARD)
|
|
|
|
LAGER - ALCOHOL(CRM STANDARD)
|
|
|
|
LAGERSTROEMIA INDICA EXTRACT
|
|
|
|
Laf1 protein
|
|
|
|
LAF-4 protein
|
|
|
|
LAFUN
|
|
|
|
Lafutidine
|
118288-08-7
|
C22H29N3O4S
|
|
L-A-GLYCERYLPHOSPHORYLCHOLINE(GPC)
|
4217-84-9
|
|
|
LAG-3 (Lymphocyte Activation Gene-3, FDC Protein, CD223) (ATTO 488)
|
|
|
|
LAG-3 (Lymphocyte Activation Gene-3, FDC Protein, CD223)
|
|
|
|
LAG-3 (Lymphocyte Activation Gene-3, FDC Protein, CD223) (ATTO 647)
|
|
|
|
LAG-3 (Lymphocyte Activation Gene-3, FDC Protein, CD223) (FITC)
|
|
|
|
LAG-1 (Lymphocyte activation gene-1 protein)
|
|
|
|
LAG-3 (Lymphocyte Activation Gene-3, FDC Protein, CD223) (A)
|
|
|
|
LAG-3 (Lymphocyte Activation Gene-3, FDC Protein, CD223) (Biotin)
|
|
|
|
LAG-3 (Lymphocyte Activation Gene-3, FDC Protein, CD223) (ATTO 590)
|
|
|
|
L-a-Glycerophosphorylethanolamine (hydrate) (olamine alfoscerate) (GPE)
|
35907-34-7
|
|
|
L-a-Glycerophosphorylinositole-Calcium salt (GPI-Ca)
|
135821-52-2
|
|
|
L-A-GLYCEROPHOSPHORYLETHANOLAMINE*FROM E COLI
|
33049-08-0
|
|
|
L-A-GLYCERYLPHOSPHORYLCHOLINE HYDRATE
|
|
|
|
Lagochilline
|
131898-43-6
|
C20H36O5
|
|
LAGOCHILINE
|
|
C20H36O5
|
|
La(hfac)3
|
|
|
|
laherradurin
|
|
|
|
LAG-3 protein C. elegans
|
|
|
|
LAG1 protein
|
156739-75-2
|
|
|
LAG-1 protein, Caenorhabditis
|
|
|
|
Lag-2 protein
|
|
|
|
LAG-1 protein
|
|
|
|
lag-1 protein, Legionella
|
|
|
|
LB-1
|
|
|
|
LB 145
|
|
|
|
lagunamycin
|
150693-65-5
|
C19H21N3O4
|
|
LAIBODANG EXTRACT
|
|
|
|
laidlomycin butyrate
|
78734-45-9
|
|
|
LAH(4) protein
|
|
|
|
L-aIle-L-Pro-N-Methyl-Gly-N-methyl-L-Val-OMe
|
55555-43-6
|
|
|
L-A-HYDROXYGLUTARIC ACID ZINC
|
|
C5H6O5Zn
|
|
L-A-HYDROXYGLUTARIC ACID DISODIUM
|
|
C5H6Na2O5
|
|
L-A-HYDROXYGLUTARIC ACID DISODIUM)
|
63512-50-5
|
C5H6O5Na2
|
|
LAIR-1, aa22-125, Extracellular Domain, Recombinant, Human (Leukocyte-associated Ig-like Receptor-1)
|
|
|
|
LAIR-1a (Leukocyte-associated Ig-like Receptor-1a)
|
|
|
|
LAI regimen
|
|
|
|
LAIR-1( Extracellular domain , 22-125aa, human), Recombinant, E.coli
|
|
|
|
LAIR-1 (Leukocyte-associated Ig-like Receptor-1) (FITC)
|
|
|
|
LAIR-1 (Leukocyte-associated Ig-like Receptor-1) (A)
|
|
|
|
LAIR-1, Low Endotoxin (Leukocyte-associated Ig-like Receptor-1)
|
|
|
|
LAIR-1 (Leukocyte-associated Ig-like Receptor-1) (Azide Free)
|
|
|
|
LAIR-1 (Leukocyte-associated Ig-like Receptor-1), 40kD, Clone: NKTA255, Mab anti-Human, FITC, flow
|
|
|
|
LAIR-1 (Leukocyte-associated Ig-like Receptor-1)
|
|
|
|
LAIR-1 (Leukocyte-associated Ig-like Receptor-1), 40kD, Clone: NKTA255, Mab anti-Human, endotoxin low, flow/IP/WB/functional assays
|
|
|
|
LAIR-1 (Leukocyte-associated Ig-like Receptor-1), 40kD, Clone: NKTA255, Mab anti-Human, RPE
|
|
|
|
LAIR-1 (Leukocyte-associated Ig-like Receptor-1), 40kD, Clone: NKTA255, Mab anti-Human, azide-free, flow/IP/WB/functional assays
|
|
|
|
LAIR-1 (Leukocyte-associated Ig-like Receptor-1) (Biotin)
|
|
|
|
LAIR-1 (Leukocyte-associated Ig-like Receptor-1) B
|
|
|
|
LAIR-1 (Leukocyte-associated Ig-like Receptor-1), 40kD, Clone: NKTA255, Mab anti-Human, Biotin
|
|
|
|
LAIR-1 (Leukocyte-associated Ig-like Receptor-1), 40kD, Clone: NKTA255, Mab anti-Human, flow/IP/WB
|
|
|
|
LAIR-2 receptor
|
|
|
|
LAITAN
|
|
|
|
LAKANKA
|
|
|
|
LAKE AMARNATH
|
|
|
|
LAKE CHOCOLATE BROWN HT
|
|
|
|
Lakefordbsc
|
|
|
|
LakeRedC-B
|
|
|
|
Pigment Red 53:1
|
5160-02-1
|
C34H24BaCl2N4O8S2
|
|
LAKES(COLOURINGS)
|
|
|
|
LAKE SUPERIOR FISH TISSUE - PCBS, CHLORINATED PESTICIDES AND FATTY ACIDS(CRM STANDARD)
|
|
|
|
LAKE SEDIMENTS - DIXON AND FURAN CONGENERS (REFERENCE VALUES)(CRM STANDARD)
|
|
|
|
LB Agar, Powder
|
|
|
|
LB-AGAR MEDIUM
|
|
|
|
LB AGAR AMPICILLIN-100
|
|
|
|
LB AGAR, VEGITONE
|
|
|
|
LB AGAR CARBENICILLIN-100
|
|
|
|
LB AGAR TABLETS TO MAKE 50ML,*TRU-MEASUR E CHEMICAL
|
|
|
|
LB-AGAR FOR LAMBDA
|
|
|
|
LBB
|
52748-86-4
|
C23H26N2O3S
|
|
L-Baiklain
|
|
C6H9NO2
|
|
L-ALA
|
|
C9H18N4O2
|
|
2-[[2-[L-Ala-Amino]benzyl]sulfinyl]-1H-benzimidazole
|
|
|
|
2-[[2-[L-Ala-Amino]benzyl]thio]-1H-benzimidazole
|
|
|
|
L-Ala-βAbu-OH
|
|
|
|
L-ALA-ALA-ALA-L-TYR-L-ALA-ALA-ALA
|
|
C27H41N7O9
|
|
L-ALA-ALA-ALA-ALA-L-GLU-GLU-GLU
|
|
C27H43N7O14
|
|
L-ALA-ALA-ALA-L-PRO-L-ALA
|
|
C17H29N5O6
|
|
L-ALA-ALA-L-PHE-ALPHA-NAPHTHYLAMIDE
|
|
C25H28N4O3
|
|
L-ALA-ALA-ALA-L-PRO
|
|
C14H24N4O5
|
|
L-ALA-ALA-ALA-ALA-ALA-ALA-ALA-ALA
|
|
C24H42N8O9
|
|
L-ALA-ALA-ALA-ALA-L-TYR-L-ALA
|
|
C24H36N6O8
|
|
L-ALA-ALA-ALA-L-PRO-L-ALA-ALA
|
|
C20H34N6O7
|
|
L-ALA-7-AMINO-4-TRIFLUORO-METHYLCOUMARIN
|
|
C13H11F3N2O3
|
|
L-ALA-ALA-ALA-L-PRO-L-TYR-L-ALA
|
|
C26H38N6O8
|
|
L-ALA(3-CYCLOBUTYL)OME
|
|
C8H15NO2
|
|
L-ALA(3-CYCLOPROPYL)OME
|
|
C7H13NO2
|
|
L-Ala-D-Ile-OH
|
|
|
|
L-Ala-D-Ala-L-Asp-L-Phe-OMe
|
|
|
|
L-Ala-D-Abu-OH
|
|
|
|
L-Ala-D-Leu-OH
|
|
|